Lack of genetic linkage evidence for a trans-acting factor having a large effect on plasma lipoprotein[a] levels in African Americans

被引:8
作者
Barkley, RA
Brown, AC
Hanis, CL
Kardia, SL
Turner, ST
Boerwinkle, E [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA
[3] Univ Mississippi, Dept Med, Jackson, MS 39216 USA
[4] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[5] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[6] Mayo Clin & Mayo Fdn, Div Hypertens, Rochester, MN 55905 USA
关键词
lasophosphatidic acid; linkage analysis; genetics; population genetics;
D O I
10.1194/jlr.M300163-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The distribution of plasma lipoprotein[a] (Lp[a]) concentrations, a risk factor for cardiovascular disease, varies greatly among racial groups, with African Americans having values that are shifted toward higher levels than those of whites. The underlying cause of this heterogeneity is unknown, but a role for "trans-acting" factors has been hypothesized. This study used genetic linkage analysis to localize genetic factors influencing Lp[a] levels in African Americans that were absent in other populations; linkage results were analyzed separately in non-Hispanic whites, Hispanic whites, and African Americans. As expected, all three samples showed highly significant linkage at the approximate location of the lysophosphatidic acid locus. The white populations also independently had regions of significant linkage on chromosome 19 (LOD 3.80) and suggestive linkage on chromosomes 12 (LOD 1.60), 14 (LOD 2.56), and 19 (LOD 2.52). No linkage evidence was found to support the hypothesis of another single gene with large effects specifically segregating in African Americans that may account for their elevated Lp[a] levels.
引用
收藏
页码:1301 / 1305
页数:5
相关论文
共 30 条
[1]  
ALBERS JJ, 1977, J LIPID RES, V18, P331
[2]  
ALBERS JJ, 1990, CLIN CHEM, V36, P2019
[3]   Multipoint quantitative-trait linkage analysis in general pedigrees [J].
Almasy, L ;
Blangero, J .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) :1198-1211
[4]   GENETICS OF THE QUANTITATIVE LP(A) LIPOPROTEIN TRAIT .3. CONTRIBUTION OF LP(A) GLYCOPROTEIN PHENOTYPES TO NORMAL LIPID VARIATION [J].
BOERWINKLE, E ;
MENZEL, HJ ;
KRAFT, HG ;
UTERMANN, G .
HUMAN GENETICS, 1989, 82 (01) :73-78
[5]  
Boerwinkle E, 2002, HYPERTENSION, V39, P3
[6]  
CAVALLI-SFORZA L L, 1971, P965
[7]   Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies [J].
Danesh, J ;
Collins, R ;
Peto, R .
CIRCULATION, 2000, 102 (10) :1082-1085
[8]   COMPARATIVE-ANALYSIS OF THE APO(A) GENE, APO(A) GLYCOPROTEIN, AND PLASMA-CONCENTRATIONS OF LP(A) IN 3 ETHNIC-GROUPS - EVIDENCE FOR NO COMMON LP(A) ALLELE AT THE APO(A) LOCUS [J].
GAW, A ;
BOERWINKLE, E ;
COHEN, JC ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2526-2534
[9]   RELATIONSHIP OF PLASMA-LIPOPROTEIN LP(A) LEVELS TO RACE AND TO APOLIPOPROTEIN-B [J].
GUYTON, JR ;
DAHLEN, GH ;
PATSCH, W ;
KAUTZ, JA ;
GOTTO, AM .
ARTERIOSCLEROSIS, 1985, 5 (03) :265-272
[10]   The significance of high levels of lipoprotein (a) compared with established risk factors in premature coronary artery disease: Differences between men and women [J].
Hahmann, HW ;
Schatzer-Klotz, D ;
Bunte, T ;
Becker, D ;
Schieffer, HJ .
ATHEROSCLEROSIS, 1999, 144 (01) :221-228